Nano Drug Delivery Systems for Colon Cancer
Innovations, Challenges, and Applications
- 1st Edition - October 1, 2026
- Latest edition
- Editors: Arun Kumar Singh, Vipan Kumar, Pranav Kumar Prabhakar, Meenakshi Dhanawat, Neeraj Mishra
- Language: English
Nano Drug Delivery for Colon Cancer: Innovations, Challenges, and Applications is a breakthrough exploration that delves into the latest advancements in colon cancer diagno… Read more
World Book Day celebration
Where learning shapes lives
Up to 25% off trusted resources that support research, study, and discovery.
Description
Description
It serves as a vital resource, fostering interdisciplinary knowledge and advancements that have the potential to revolutionize colon cancer therapeutics. The book's interdisciplinary approach ensures it is a beacon of knowledge for those seeking to navigate and innovate within this critical field.
Key features
Key features
- Delivers an in-depth exploration of the design, synthesis, and application of nanodrug delivery systems
- Unveils groundbreaking and state-of-the-art approaches in colon cancer diagnosis and treatment, placing readers at the cutting edge of medical innovation
- Showcases how strategic design methodologies can dramatically boost therapeutic efficacy, paving the way for more effective colon cancer treatments
Readership
Readership
Table of contents
Table of contents
2. Current trends of targeted nanoparticulate carriers for the treatment of colon cancer
3. Lipid nanocarrier-based drug delivery for the treatment of colon cancer
4. Liposomal Nanomedicine: Applications for Drug Delivery in Cancer Therapy
5. siRNA polymer conjugates for the delivery of RNAi therapeutics for the treatment of Colon Cancer
6. Carbon-Based Quantum Dots and Nanotubes for Colon Cancer Targeting and Drug Delivery
7. Recent trends of extracellular vesicles for therapeutic intervention of Colon Cancer
8. Mitochondria-targeted drug delivery systems for the effective treatment of colon cancer
9. Revolutionizing Colon Cancer Care: Advances in Carbon-Based Materials as theranostic agents
10. Surface modified Metal Nanoparticles in Colon Cancer Therapy
11. Nano-based Phyto drug delivery systems for the management of colon cancer
12. Role of polymeric nanoparticles for the treatment of Colon cancer
13. Nanomicelles based drug delivery systems as for targeted therapy of colon cancer
14. Regulatory framework in the Nanomedicine targeting Colon Cancer
15. Current and future perspectives of nanomedicine in colon cancer treatment
Product details
Product details
- Edition: 1
- Latest edition
- Published: October 1, 2026
- Language: English
About the editors
About the editors
AS
Arun Kumar Singh
Arun Kumar Singh holds an M.Pharm in Pharmaceutics from Galgotias University, India, and serves as an Assistant Professor in the Department of Pharmacy at Vivekanand Global University. He is actively engaged in teaching and interdisciplinary research spanning nano-formulation, artificial intelligence, machine learning, big data analytics, IoT, blockchain, cancer biology, and neuroscience.
Mr. Singh has made substantial scholarly contributions, authoring one book with IOP Publishing, five book chapters with River Publishers, and 28 review articles in reputed journals, including high-impact publications in Biochimica et Biophysica Acta (BBA) – Reviews on Cancer.
In addition, he has authored and edited 58 books with leading publishers such as Elsevier, CRC Press, and Wiley. Known for his research acumen and leadership, Mr. Singh is committed to advancing pharmaceutical sciences through innovation and interdisciplinary collaboration, with a focus on impactful healthcare solutions.
VK
Vipan Kumar
Dr. Vipan Kumar is an Associate Professor at the School of Pharmaceutical Sciences, CGC University, Mohali, India. He received his PhD in Pharmaceutical Sciences from Maharshi Dayanand University, Rohtak, India, where he was awarded fellowship support from the University Grants Commission (UGC), New Delhi. Dr. Kumar’s research focuses on medicinal chemistry, nanotechnology-based drug delivery, and the development of novel therapeutic agents for cancer and metabolic disorders. Dr. Kumar has published over 35 research and review articles in peer-reviewed national and international journals and has authored and edited 04 national and international books, along with several book chapters. He also holds 04 Indian patents in the areas of drug discovery and nanomedicine. His academic achievements have been recognized with several honors, including the Backbone Award (2025–26) from CGC University, Mohali, and the Devi Lal Memorial Award (2020–21) from JCD Vidyapeeth, Sirsa, for excellence in teaching and research. Dr. Kumar serves on the editorial boards of multiple international journals and acts as a reviewer for several reputed publications. He has delivered more than 30 oral and poster presentations at national and international scientific meetings and actively contributes to academic governance and policy development through his roles in ethical committees, inspection teams, examination committees, and university Boards of Studies.
PP
Pranav Kumar Prabhakar
Dr. Pranav Kumar Prabhakar is currently working as a Professor and Head at Department of Biotechnology, School of Engineering and Technology, Nagaland University, Meriema, Kohima, Nagaland, India. He is among the World’s Top 2% Scientists (list published by Stanford University, USA, 2021, 2022, 2023, 2024, and 2025). He completed his PhD in Biotechnology from IIT Madras. His research focuses on elucidating molecular mechanisms and strategies for oral insulin delivery and mimicking signaling pathways in metabolic disorders (diabetes) using natural products. Dr. Pranav is a member of the Royal Society of Chemistry and the Asia-Pacific Chemical, Biological & Environmental Engineering Society. He serves as an editorial board member and reviewer for many reputed national and international journals. His honors include a travel grant from IIT Madras and the Council for Scientific and Industrial Research (CSIR) to attend ATTD 2009 in Greece, approved by the Department of Science and Technology (DST). He has published over 160+ research articles, authored/edited 24 books, and 48 book chapters, and delivered 9 oral and poster presentations at scientific meetings.
MD
Meenakshi Dhanawat
Dr Meenakshi Dhanawat, is currently working as Associate Professor in Amity Institute of Pharmacy, Amity University Haryana. She has a background in Pharmaceutical Sciences with a specialization in Medicinal Chemistry. She has done Masters from NIPER, Mohali and the project was based on Glycosylamino acids. Her PhD is from IIT-BHU, Varanasi and she worked on CNS drug delivery targeting 5HT1A/2A receptor. Apart from that she has a vast experience in the extraction of herbal drugs. Area of interest are Synthetic Chemistry, Heterocyclic Chemistry, Nanotechnology, Drug Delivery, Prodrug and Co-Drug Drug Design Complexation, Polymer Chemistry, and their application in drug delivery.
She has 17 years of teaching and research experience. She has attended several national and international conferences in india and abroad the recipient of the travelship award in DDD section of AAPS-2010, National Biotechnology Conference, California, USA. She has been able to grab the international travel grant from DBT and DST for attending the International Conference at California, USA and Munich, Germany Respectively. She has also grabbed many other fellowships awards, which includes Rajiv Gandhi National Fellowship. She has Published more than 85 Research/Reviews along with Patent-06, Books 6, Book Chapter 22, Book Editor 02, Copyright 01.
NM